Valuation Merck KGaA

Equities

Real-time Estimate Tradegate Other stock markets 11:12:12 10/09/2024 BST			5-day change	1st Jan Change
170.15 ^EUR	+0.15%		-2.04%	+18.25%

09-09	German Shares Cheer Likelihood of September ECB Rate Cut	MT
09-03	Merck Gets EU Approval for Keytruda Cancer Therapy	DJ

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	45,804	61,021	98,695	78,651	62,651	73,869	-	-
Change	-	33.22%	61.74%	-20.31%	-20.34%	17.9%	-	-
Enterprise Value (EV) ¹	58,160	71,683	107,596	86,979	70,610	80,782	78,871	76,436
Change	-	23.25%	50.1%	-19.16%	-18.82%	14.41%	-2.37%	-3.09%
P/E ratio	34.7x	30.7x	32.3x	23.6x	22.2x	24.7x	20.7x	18.7x
PBR	2.56x	3.59x	4.63x	3.03x	2.35x	2.56x	2.36x	2.17x
PEG	-	0.6x	0.6x	2.68x	-1.5x	4.16x	1.1x	1.8x
Capitalization / Revenue	2.84x	3.48x	5.01x	3.54x	2.98x	3.45x	3.27x	3.12x
EV / Revenue	3.6x	4.09x	5.47x	3.91x	3.36x	3.77x	3.49x	3.23x
EV / EBITDA	13.3x	13.8x	17.6x	12.7x	12x	13.3x	11.8x	10.6x
EV / EBIT	27.4x	24x	25.7x	19.4x	19.6x	20.7x	17x	15x
EV / FCF	28.5x	34.7x	30.3x	31.9x	36.9x	27.4x	24.2x	19.8x
FCF Yield	3.51%	2.88%	3.3%	3.14%	2.71%	3.65%	4.13%	5.05%
Dividend per Share ²	1.3	1.4	1.85	2.2	2.2	2.306	2.573	2.751
Rate of return	1.23%	1%	0.81%	1.22%	1.53%	1.36%	1.51%	1.62%
EPS ²	3.04	4.57	7.03	7.65	6.49	6.875	8.223	9.071
Distribution rate	42.8%	30.6%	26.3%	28.8%	33.9%	33.5%	31.3%	30.3%
Net sales ¹	16,152	17,534	19,687	22,232	20,993	21,408	22,581	23,650
EBITDA ¹	4,385	5,201	6,103	6,849	5,879	6,055	6,706	7,214
EBIT ¹	2,120	2,985	4,179	4,474	3,609	3,907	4,644	5,096
Net income ¹	1,320	1,987	3,055	3,326	2,824	2,994	3,557	3,908
Net Debt ¹	12,356	10,662	8,902	8,328	7,959	6,913	5,002	2,567
Reference price ²	105.35	140.35	227.00	180.90	144.10	169.90	169.90	169.90
Nbr of stocks (in thousands)	434,778	434,778	434,778	434,778	434,778	434,778	-	-
Announcement Date	05/03/20	04/03/21	03/03/22	02/03/23	07/03/24	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
MERCK KGAA	24.71x	3.77x	13.34x	+1.36%	81.56B
KYOWA KIRIN CO. LTD.	25.19x	2.83x	12.01x	+1.79%	11.99B
YUHAN CORPORATION	59.89x	4.35x	51.25x	+0.35%	6.74B
SK BIOPHARMACEUTICALS CO., LTD.	114.7x	15.23x	83.31x	-.--%	6.09B
BETTA PHARMACEUTICALS CO., LTD.	31.81x	5.76x	17.88x	+0.71%	2.17B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	11.6x	-	-	+17.24%	1.97B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	30.07x	-	-	-	1.9B
SUPERNUS PHARMACEUTICALS, INC.	116.93x	-	-	-	1.87B
INDIVIOR PLC	10.44x	1.05x	3.65x	-.--%	1.33B
Average	47.26x	5.50x	30.24x	+3.06%	12.85B
Weighted average by Cap.	32.87x	4.35x	19.37x	+1.52%